LEILA SAHNI to Systemic Inflammatory Response Syndrome
This is a "connection" page, showing publications LEILA SAHNI has written about Systemic Inflammatory Response Syndrome.
Connection Strength
0.256
-
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
Score: 0.167
-
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation. Pediatr Infect Dis J. 2023 06 01; 42(6):e190-e196.
Score: 0.045
-
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatr Infect Dis J. 2022 11 01; 41(11):891-898.
Score: 0.044